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The capacity to regulate their internal ionic composition is 
a fundamental property of free-living terrestrial organisms 
(Stewari and Broadus, 1987). This is accomplished by ad- 
justing the movement of ions or water (or both) between 
cells and various extracellular compartments, including 
those communicating with the external environment. Of 
the complement of inorganic ions in such organisms, Ca2+ 
performs an especially large number of intracellular and 
extracellular functions. It is a well-known intracellular sec- 
ond messenger, controlling numerousvital processes(see 
minireview by Bootman and Berridge, 1995 [this issue of 
Ce//]). The cytosolic free Ca2+ concentration ([CaZ+li) un- 
dergoes rapid and often substantial (i.e., severalfold or 
more) fluctuations in response to extracellular first mes- 
sengers binding to their cognate receptors on target cells. 
The extracellular ionized Ca2+ concentration ([CaZ+lO), in 
contrast, is maintained stably at - 1 mM, at least lO,OOO- 
fold higher than the resting level of [Ca2+li in most cells, 
providing a seemingly inexhaustible supply of Ca2+ for its 
diverse intracellular functions. Caz+ is also an essential 
component or cofactor in key extracellular structures or 
processes (i.e., bone, clotting factors, and adhesion mole- 
cules) whose biological functions could be compromised 
by large changes in [Ca2+10, with potentially disastrous con- 
sequences. It is not intuitively obvious, therefore, that Ca2+ 
serves as an important extracellular first messenger. The 
recent cloning of an extracellular CaZ+-sensing receptor 
(CaR), however, has firmly established that [Ca2+],, serves 
such an informational role (Brown et al., 1993). This mini- 
review will briefly outline the signaling function of [Ca2+10, 
particularly the role of [CaQsensing mechanisms within 
various extracellular compartments in this process. 
The [Ca2+], Signal 
For extracellular Ca2+ to serve an informational role, it must 
undergo sufficiently large perturbations to be recognized 
by [Ca2+],-sensing mechanisms (or the responsiveness of 
the latter must change). In mammals, blood-ionized Ca*+ 
varies by only a few percent over the course of a day or 
even much of a lifetime. This remarkable stability of [CaZ+], 
results from a homeostatic system with two principal ele- 
ments: [CaZ+],-sensing cells (e.g., parathyroid cells) and 
tissues that respond to either local or systemic signals 
from these [Ca2+],-sensing cells by altering their transloca- 
tion of Ca2+ into or out of the extracellular fluid (i.e., kidney, 
intestine, and bone) (Stewart and Broadus, 1987). The 
near constancy of the blood-ionized CaZ+ concentration 
underscores the exquisite responsiveness of [Ca2+10- 
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sensing cells to minute (- 2%) fluctuations in [Caz+],. Para 
doxically, however, it has also deflected attention from the 
potential informational content of the extracellular ionic 
composition and appears to have fostered the concept 
that [Ca2+10 is, in a broader sense, nearly invariant. It is 
not. Within the numerous extracellular compartments in 
complex organisms, some have levels of [Ca2+la differing 
considerably from that measured in blood. Moreover, 
these compartments can undergo substantial changes in 
[Ca2+10 due to alterations in the fluxes of Ca’+ into or out 
of the extracellular space in question. 
[Ca*+],within bodily cavities communicating with the ex- 
ternal environment (the gastrointestinal and genitourinary 
tracts) undergoes large changes related to the assimilation 
of nutrients or excretion of wastes. Urinary tonicity, for 
example, varies over a >lO-fold range without accompa- 
nying changes in the total amounts of Ca’+, Mg2+, or other 
ions excreted. At their normal levels of - 1 mM within 
various extracellular compartments, CaZ+ ions are nearly 
saturated with respect to their phosphate and oxalate salts 
(e.g., in the urinary tract). Thus, even small increases in 
urinary Ca2+ concentration could entail substantial risk of 
such salts precipitating. As will be described below, a 
[Ca*+],,-sensing mechanism has been positioned oppor- 
tunely within the urinary tract to minimize this risk. 
A gradient for [Ca’+],, has been described in the skin, 
with generally higher levels in the superficial cellular layers 
(Menon et al., 1985):This gradient may serve an informa- 
tional role, being sensed by keratinocytes (Hennings et 
al., 1980) and promoting theirdifferentiation from the basal 
layer of continuously proliferating cells to the skin surface, 
where the superficial, cornified cells die and are sloughed 
off. There is also a [Ca’+&, gradient across the placenta, 
with active transplacental Ca*+ transport producing a level 
of [Ca2+10 - 10% higher in the fetal than the maternal circu- 
lation (Reitz et al., 1977). 
Prior to birth, [CaZ+lo within the fluid-filled alveoli of the 
developing lungs of the fetal sheep is -0.5 mM. Postna- 
tally, the fluid lining of the alveoli is reduced to a thin layer, 
the hypophase, with a [Cap+]0 that has increased 3- to 4-fold 
(to 1.6-2 mM) (Eckenhoff, 1989). The hypophase contains 
the phospholipid surfactant, which is essential for pre- 
venting alveolar collapse. Optimal deposition of surfactant 
on the alveolar lining cells takes place at levels of [Ca2+10 
of l-2 mM. The surfactant-containing, lamellar bodies of 
the type 2 pneumocytes contain abundant Ca*+ (as much 
as 75 mM). Therefore, exocytosis of the lamellar bodies 
provides not only surfactant but also Ca2+ that is essential 
for this phospholipid to function properly at this critical air- 
fluid interface. 
[Ca”], in narrow intercellular spaces within the brain 
can be surprisingly labile given the - lO,OOO-fold higher 
level of [Caz+jo relative to resting levels of [Ca”],. Evoking 
neuronal activity ranging from physiological activation 
(stimulating sensory neurons within the somatosensory 
cortex by stroking a cat’s paw [Nicholson et al., 19771) to 
Cell 
660 
induction of seizure-like activity in the cerebellum of an 
anesthetized rat (Heinemann et al., 1977), decreases 
[Ca”], reversibly by anywhere from 20% to as much as 
90%. Stimulation of glutamate receptor channels in rat 
hippocampal pyramidal neurons likewise decreases 
[Ca2+lo (Stabel et al., 1990) owing to activation of Ca’+ 
influx through the plasma membrane. The stimulation 
of cation-nonselective (e.g., NMDA and AMPA/kainate) 
channels may contribute to concomitant increases in [K+], 
and reductions in [Na+], in this circumstance. The latter 
can secondarily affect [CaZ+],,. For example, decreasing 
[Na+], in hippocampal slices from 154 to 114 mM (which 
also reduces osmolality proportionately) substantially re- 
duces [Ca2+10, probably through a mechanism involving 
the Na+/Ca’+ exchanger (Chebabo et al., 1995). The latter 
effects raise the intriguing possibility that osmosensing in 
mammalian species could involve, in part, the sensing of 
osmolality-elicited changes in [CaZ+],. There are also large 
fluxes of Ca*+ into and out of the restricted synaptic space. 
Synaptic vesicles can contain abundant Ca2+ (up to - 10 
mmollkg) that is released exocytotically from presynaptic 
neurons along with neurotransmitters. Subsequent activa- 
tion of Cap+-permeable channels on postsynaptic neurons 
results in a large influx of Ca’+, which could produce sub- 
stantial reductions in [Ca2+],, within the synaptic cleft. 
Like secretory vesicles, the lumen of the endoplasmic 
reticulum accumulates considerable (millimolar) quanti- 
ties of Ca*+ that are released by intracellular messengers 
such as inositol trisphosphate, cytosolic CaZ+ per se, and 
cyclic ADP-ribose (Bootman and Berridge, 1995). Could 
Ca*+ sensors monitor the extent of filling of the endoplas- 
mic reticulum or other membrane-enclosed compartments 
that accumulate Ca2+, thereby contributing to “spontane- 
ous” release of Ca2+? 
How Cells Sense [Ca2+], 
Parathyroid cells and other cell types express a CaR that 
provides an illustrative example of how specific cells rec- 
ognize and respond to the [CaZ+10 signal. The CaR recog- 
nizes not only [Ca”], and other divalent cations (Mg’+, 
Ba2+, and ST*+), but also trivalent cations of the lanthanide 
series (e.g., Cd”+) and even organic polycations such as 
protamine, polylysine, and neomycin. The surprising pro- 
miscuity of the receptor may be of biological significance, 
as the CaR probably functions as a [Mg*+&, sensor in vivo 
(see below) and could potentially also recognize other en- 
dogenous polycationic ligands present at concentrations 
appropriate for interacting with the receptor. By Northern 
blot analysis, the CaR is expressed most abundantly in 
mammalian parathyroid and kidney but also at lower levels 
in other tissues, including thyroid (specifically the [Ca2+10- 
sensing thyroidal C cells), intestine, lung, and various re- 
gions of brain (Brown et al., 1993; Ruat et al., 1995). In 
parathyroid and C cells, it may represent the principal me- 
diator of [Ca”],-elicited changes in parathyroid hormone 
(PTH) and calcitonin secretion. It is unclear how the para- 
thyroid cell reverses the usual stimulatory effect of Ca*+ 
on exocytosis, producing the atypical, inverse relationship 
between both [Caz+], and [CaZ++li on the one hand and PTH 
secretion on the other. 
Several inherited diseases of extracellular Ca2+ homeo- 
stasis result from CaR mutations, and these “experiments 
in nature” have provided valuable insights into the normal 
functions of the receptor. Familial hypocalciuric hypercal- 
cemia (FHH) and neonatal severe hyperparathyroidism 
(NSHPT) are the phenotypes resulting from inactivating 
mutations of the receptor when present in the heterozy- 
gous and homozygous states, respectively (reviewed by 
Brown et al., 1995). It is also clear, however, that mutations 
in the CaR, which resides on chromosome 3, are not the 
only genetic basis for the FH H phenotype. A locus on chro- 
mosome 19, as well as one linked to neither chromosome 
3 nor 19, has also been identified, but the responsible 
genes have not yet been identified (Heath et al., 1993; 
reviewed by Brown et al., 1995). Higher than normal con- 
centrations of [Ca”], are present in affected individuals 
with inactivating CaR mutations, with mild hypercalcemia 
(- 1 O%-20% above the upper limit of normal) in heterozy- 
gotes and severe hypercalcemia (1.5- to P-fold elevations 
in [CaP+],) in homozygotes. The hypercalcemia results in 
large part from a gene dose-dependent “resistance” of 
the parathyroid glands to [Cap+lO, but affected individuals 
with FHH and NSHPT also manifest diminished respon- 
siveness to [Ca2+]0 in other tissues. The CaR normally reg- 
ulates renal tubular reabsorption of CaZ+ in the thick as- 
cending limb of the nephron, with increased levels of 
[Ca2+], on the basal (i.e., blood) side of the tubule inhibiting 
Ca2+ reabsorption. Therefore, the reduced responsive- 
ness of the renal CaR to [Ca*+], in FHH and NSHPT leads 
to excessive renal tubular Ca’+ reabsorption of CaZ+ ions 
that contributes to the maintenance of hypercalcemia 
(Brown et al., 1995). 
The CaR is also present in the renal collecting ducts, 
where it antagonizes the stimulatory action of vasopressin 
on water permeability under normal circumstances, pre- 
sumably through CaR-mediated changes in water channel 
function or availability in the apical membrane of the col- 
lecting duct. Patientswith FHH, on theother hand, concen- 
trate their urine normally despite being hypercalcemic (be- 
cause of resistance of the collecting duct CaR to [Ca*+],) 
(Brown et al., 1995). CaRs in the thick ascending limb and 
collecting duct, therefore, may function coordinately to 
balance the homeostatic needs of free-living terrestrial or- 
ganisms with respect to Ca*+ and water. With Ca2+ excess, 
the CaR in the thick limb reduces renal tubular CaZ+ reab- 
sorption, resulting in increased urinary Ca*+ loads. If uri- 
nary concentration continued unabated, the resultant 
increase in urinary Ca2+ concentration might cause precip- 
itation of Ca2+-containing salts. Therefore, inhibition of uri- 
nary concentrating ability under these circumstances 
could serve to reduce the risk of kidney stones or tissue 
CaZ+ deposition. 
Patients harboring activating mutations of the CaR, in 
contrast, exhibit a generally benign form of autosomal 
dominant hypocalcemia. In these patients, the CaR has 
an increased basal (i.e., [Ca’+],-independent) activity, in- 
creased affinity for [Ca2+],, or both (reviewed by Brown et 
al., 1995), such that the level at which [CaZ+lo is maintained 
by the homeostatic system is “reset” downward. As might 
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be expected from the preceding discussion on inactivating 
mutations, some affected individuals with activating muta- 
tions show marked increases in renal Ca2+ excretion and 
impaired urinary concentrating ability as [Ca*+], is in- 
creased from its resting hypocalcemic level, presumably 
because of increased responsiveness of CaRs within the 
kidney to [Ca2+10. 
Several general statements can be made about the 
functions of the CaR as they relate to maintenance of 
[Ca2+10 homeostasis (Figure 1). First, the CaRs in parathy- 
roid cells and C cells sense levels of [Ca2+Jo that reflect 
systemic Ca2+ homeostasis and adjust calciotropic hor- 
mone secretion appropriately to normalize [Ca*+],,. The 
CaR on renal epithelial cells, on the other hand, senses 
[Ca2+10 locally within the kidney and modulates the actions 
of other hormones (e.g., PTH or vasopressin) on solute 
and water flow to achieve the desired level of [Caz+], in 
blood and urine. Second, the polarity of the CaR (e.g., 
whether it is apical or basal-facing the external or internal 
environment of the organism, respectively) is critical in 
determining the compartment in which [Ca2+],, is sensed 
and the resultant modifications in ion transport, water flow, 
or other CaR-regulated processes. 
What is the function of the CaR in tissues that are not 
involved in systemic [Ca2+],, homeostasis? The CaR in 
brain is present in several regions, including hippocam- 
pus, hypothalamus, and cerebellum, where it may sense 
local rather than systemic levels of [Ca*+10 (or perhaps 
some other endogenous CaR ligand) within the brain or 
cerebrospinal fluid. Ruat et al. (1995) have used immuno- 
histochemistry to localize the CaR to nerve endings, in- 
cluding those on blood vessels. In view of the nerve cell- 
dependent changes in [Ca’+],, within the brain discussed 
above, it is plausible to suggest (Ruat et al., 1995) that 
the neuronal CaR recognizes and responds to local 
changes in [Ca2+],, resulting from varying levels of synaptic 
and neuronal activity. Figure 2 illustrates schematically 
a 
Ca2* X CaZc 
Figure 1. Schematic Representation of Possible Ways in Which CaRs 
(or Other Ion-Sensing Receptors) Might Regulate Epithelial Cell Func- 
tion 
The Ca*+ sensor (shown for the sake of argument with the CaR serpen- 
tine motif) could regulate the following processes: apical transport in 
responses to signals from apical (1) or.basal(4) CaRs, basal transport 
in response to basal CaRs (3) trafficking of transporter-containing 
vesicles (2), or loading of intracellular Ca2+ stores (5). 
Figure 2. Hypothetical Ways in Which CaRs Could Regulate the Func- 
tion of Hippocampal Pyramidal Neurons Presynapticallyor Postsynap- 
tically 
The CaR (or another sensor for Ca*+ or some other ion) is shown as 
regulating presynaptic, voltage-dependent Ca* channels (VDGC) via 
receptors either within (3) or outside (1) of the synaptic cleft or postsyn- 
aptic VDDC or glutamate receptor-operated channels (ROC) through 
receptors inside (4) or outside (5) of the synaptic space. The CaR might 
also regulate exocytosis of synaptic vesicles or the loading of such 
vesicles.with Ca*+. 
how neuronal CaRs might function depending on their lo- 
cation on the cell. 
It is intriguing that the CaR is present within the hippo- 
campus, which also contains the metabotropic glutamate 
receptors (mGluRs), to which the CaR bears a striking 
similarity in its overall topology (Brown et al., 1993; Nakani- 
shi, 1992). Did the two receptors arise from a common 
ancestor by fusion of a “sensing” domain for small charged 
molecules (which perhaps originated from the bacterial 
periplasmic binding proteins [Conklin and Bourne, 1993]), 
to a serpentine signal-transducing domain? Could the 
CaR, like the mGluRs, be involved in long-term potentia- 
tion and other processes in hippocampal pyramidal neu- 
rons related to learning and other cognitive functions? 
It seems likely that there are additional forms of CaRs or 
sensors that mediate the numerous effects of extracellular 
CaZ+ that have been described on various cell types (re- 
viewed by Brown, 1991). For instance, elevations in [CaZ+10 
reduce PTH gene expression and directly or indirectly in- 
hibit parathyroid cellular proliferation. [Ca*+],, also inhibits 
osteoclastic bone resorption, in association with changes 
in [Ca*+li reminiscent of those in parathyroid cells. Further- 
more, raising [Ca2+lo inhibits the proliferation and pro- 
motes the differentiation of keratinocytes (Hennings et al., 
1980) and also modulates the growth, differentiation, or 
both of cultured mammary cells and various other epithe- 
lial cells. It is not yet clear which of these actions of [Ca2+10 
are mediated by the recently cloned CaR and which reflect 
the actions of additional [Ca2+Jo sensors. It is likely that 
other forms of [CaZ+Jo sensors exist, as the pharmacologic 
profile for the inhibitory actions of [CaZ+lo and other polyva- 
lent cations on osteoclasts, for instance, differs distinctly 
from that of the parathyroid CaR. cDNAs encoding a puta- 
tive CaR related to the low density lipoprotein superfamily, 
which is expressed on parathyroid cells, placental cyto- 
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trophoblasts, and kidney proximal tubules, have recently 
been isolated but have not yet been characterized func- 
tionally in terms of their [Ca*+]&ensing properties (Lund- 
gren et al., 1994; Saito et al., 1995). Much additional work 
is required, therefore, to define the nature of the [Ca2+10 
sensors mediating the effects of [Ca”], on epithelial cells 
and other cell types and the signal(s) to which such [Ca2+la 
sensors respond in situ. Presumably, diseases of [Ca2+la 
sensing in addition to those described to date for the CaR 
may result from dysfunction of such [Ca2+la sensors. 
Are There Sensors for Additional ions? 
Changes in the concentrations of extracellular ions other 
than CaZ+ modulate the functions of various cell types in 
ways that suggest the presence of specific ion-sensing 
mechanisms (reviewed by Brown, 1991). The CaR in the 
thick ascending limb mediates inhibitory actions of ele- 
vated levels of not only [Ca2+], but also [MS”],, on tubular 
reabsorption of both ions. Patients with FHH can have mild 
hypermagnesemia, while those with untreated NSHPT 
may show more substantial increases in [Mg”], (Brown 
et al., 1995). Thus, direct actions of [Mg*+10 on the CaR 
in the renal thick limb (and perhaps on the parathyroid) 
may play a key role in “setting” normal levels of [Mg*+],, 
and the CaR may act as an important (if not the principal) 
[Mg2+],-sensing receptor in tetrapods. In addition, cells of 
the adrenal zona glomerulosa are exquisitely sensitive to 
changes in [K’],, responding with alterations in the produc- 
tion of the mineralocorticoid hormone, aldosterone, which 
regulates renal and gastrointestinal handling of K+. Fibro- 
blasts and other cells respond to [Ni2+],, [Cd2+],, and other 
transition metals (but not to [Ca*+10 or [Mg2+],) with alter- 
ations in phosphoinositide turnover and [Ca*+], similar to 
CaR-mediated effects on parathyroid cells (Smith et al., 
1989). Extracellular phosphate ions regulate the function 
of bone cells and kidney cells through an unknown mecha- 
nism(s). Are there receptors for [Kc],, [N?+],, and phos- 
phate ions, either G protein-coupled receptors analogous 
to the CaR or perhaps distinct forms of receptors regulat- 
ing a variety of cellular effector systems? 
Conclusions 
The cloning of a G-protein-coupled CaR from parathyroid, 
kidney, and brain and the identification of human diseases 
resulting from gain-of-function or loss-of-function muta- 
tions in the CaR have firmly established that extracellular 
Ca’+ (and probably Mg2+) can serve as a first messenger. 
The CaR enables cells to sense changes in [Ca”], that 
reflect systemic changes in [Ca*+&, homeostasis (i.e., as 
sensed by the parathyroid gland), alterations in local cellu- 
lar activity that are related to mineral ion or water metabo- 
lism (e.g., in the kidney), or local cellular functions unre- 
lated to systemic fluid and electrolyte homeostasis (i.e., 
in the vicinity of brain cells). Further studies may reveal 
the presence of additional CaRs or sensors that mediate 
specific, direct actions of extracellular Ca2+ (as opposed 
to indirect actions due solely to associated changes in 
[Ca2’li) on particular cell types. Receptors/sensors for 
other extracellular ions may also exist that represent 
mechanisms through which various cells recognize the 
informational content of their local ionic environment and 
respond in ways that produce autocrine, paracrine, or en- 
docrine/systemic effects on cellular function. 
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